Qingdao Baheal Medical INC.: 2023 Qingdao Baiyang Pharmaceutical Co., Ltd issues convertible enterprise bonds on the growth board to unspecified investors, 2024 tracking rating report.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.